Get Started Sign In

Lumere Closes Strategic Growth Capital Funding

Chicago, IL (February 11, 2019) - Lumere, Inc., a leading provider of evidence-based analytics and services to reduce unwarranted and costly clinical variation, announced today the closure of a significant round of funding led by Heritage Group. The additional capital will be used to develop and further expand service offerings that enable evidence-led change at health systems nationwide. read more

Categories

Complimentary Access to Lumere's Solutions
Tackle unwarranted variation across drugs and devices. 
No thanks. Our value analysis teams and P&T committees are not currently working to cut costs or improve outcomes.